Written summary · for readers & search
More about GSKCH (GlaxoSmithKline Consumer Healthcare)
How to read this page
- Start with the chart above - big % moves are often risky; study, don't chase FOMO.
- Check books completeness and P/E · P/B - these mean data for homework, not a green light to buy. Some statement pieces are here. Gaps remain. Study what exists - don’t invent the rest.
- Open Filings for company announcements from the exchange.
- Ask the PSX AI agent only after you've skimmed the desk - educational only, not buy/sell.
Books & valuation
- Books completeness
- Books partial - usable for study · 86
- P/B
- -
- EV/EBITDA
- -
Needs equity from a stored balance sheet
Annual · 2021-12-31 · DPS company financials table (Sales / PAT / EPS). P&L present · balance sheet not in this parse · cash flow not in this parse · source filing linked for confirmation.
YoY growth - revenue 21.8%, PAT 69.1%, EPS 69.1%.
- Balance sheet lines not in latest parse — ratios stay thin.
- Latest annual needs PAT and equity in the same year for P/B homework.
- Leverage / liquidity ratios need balance sheet fields.
Educational multiples from live/cached quote × stored books on this desk - confirm filings yourself when you want. Stock metrics explained.
GSKCH quote summary
- Last price
- PKR 124.21
- Change
- -54.70%
- Day range
- PKR 120 - PKR 124.25
- Volume
- 8,500
Recent filings
- 06/01/2023 · Approval of Company Name Change - Haleon Pakistan Limited
- 05/12/2022 · Results of the Board of Directors Meeting Other than Financial Results
- 05/12/2022 · CTC of Special Resolutions Passed in the Extraordinary General Meeting 2022
- 25/11/2022 · Notice of Board Meeting Other Than Financial Results
- 14/11/2022 · Notice of Extraordinary General Meeting - 2022
Other PHARMACEUTICALS share prices
Same sector on the board - open another name for homework; not a peer ranking or buy list.
- ABOTAbbott Laboratories (Pakistan) Limited
- AGPAGP Limited
- BFBIOBF Biosciences Limited
- CPHLCiti Pharma Ltd.
- FEROZFerozsons Laboratories Limited
- GLAXOGlaxoSmithKline Pakistan Limited
- HALEONHaleon Pakistan Limited
- HINOONHighnoon Laboratories Limited
- HPLHoechst Pakistan Limited
- IBLHLIBL HealthCare Limited
- LIVENLiven Pharma Limited
- LIVENRLiven Pharma Limited(Right)
GSKCH share price FAQ
What is the GSKCH share price today?
GlaxoSmithKline Consumer Healthcare (GSKCH) share price is the last traded print for the ordinary share on the Pakistan Stock Exchange. Our desk last showed about PKR 124.21 - always confirm on the live quote above. This page is educational research - not the official exchange and not a buy/sell tip.
How do I research GSKCH on Pehle Samjho?
Start with the chart, then filings and books when stored. Books ready/usable/thin describes data completeness for study - never a green light to buy. Optional: ask the PSX AI agent after you have skimmed the desk.
What does P/E mean for GSKCH?
On this desk, GSKCH P/E is shown as 6.81 when quote and stored earnings lines allow. Read the full PE ratio guide for PSX stocks, then verify filings yourself.
Where are other PHARMACEUTICALS stocks on PSX?
Browse the PHARMACEUTICALS sector hub for other listed names, or use the full PSX stock list. Open one familiar share-price page at a time.
Is this licensed advice to buy GSKCH?
No. Pehle Samjho is an educational desk about Pakistan share prices. We do not give buy/sell orders, guaranteed tips, or SECP-licensed advice.
Related PSX guides
Stay on the high-volume path: market today → stock list → company share price → beginners / metrics - tip check when a forward arrives.
- PSX market today
Pakistan stock market today in plain words - breadth, gainers, losers.
- PSX stock list
Browse all Pakistan Stock Exchange listed companies by name or sector.
- PSX stock metrics explained
Gross profit, PE, ROE, cash flow and more - for study, not tips.
- KSE 100 today
Educational constituent board - not the official index level on psx.com.pk.
- PSX for beginners
Glossary and how to read Pakistan stocks without tip-group noise.
- PSX gainers today
Biggest % rises among ordinary listed shares - homework, not a buy list.
